News
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
2d
MedPage Today on MSNNovel TKI Highly Active in HER2-Mutant Lung CancerThe investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...
How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...
3d
MedPage Today on MSNDo GLP-1 Drugs Pose a Risk to Lung Transplant Recipients?People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...
An AI tool that identifies patients at risk of lung cancer from their clinical history could help GPs refer them for tests ...
15h
inews.co.uk on MSN50,000 lung cancer patients treated late in past 10 years – and it’s getting worseUse precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...
This is part two of a two-part Healio Exclusive series on nutrition and lung health. Part one can be viewed here. Diet is an ...
Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis, published ...
Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC
Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...
A groundbreaking new urine test could soon help spot the early warning signs of lung cancer long before symptoms appear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results